SCHEMBL370835

SCHEMBL370835

Cc1cccc(C(=O)O)c1Oc1ccccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
HPGD P15428 5/20 0.54
KDM4E B2RXH2 4/20 0.54
HSD17B10 Q99714 4/20 0.54
HTT P42858 2/20 0.49
TP53 P04637 1/20 0.49
MAPK1 P28482 1/20 0.46
TSHR P16473 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 3/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
MAPT P10636 2/20 0.46
PTGS2 P35354 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
MT-CO2 P00403 1/20 0.46
LMNA P02545 1/20 0.46
TTR P02766 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27957651 0.84 MRGPRX4 (0.57) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL370837 0.81 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EHSD17B10HTT
SCHEMBL6151978 0.79 ALDH1A1 (0.62) ALDH1A1HPGDKDM4EHSD17B10MAPK1
SCHEMBL7769589 0.79 HTT (0.62) ALDH1A1HPGDKDM4EHSD17B10HTT
SCHEMBL27974766 0.77 ALDH1A1 (0.55) ALDH1A1HPGDKDM4EHSD17B10HTT
SCHEMBL11124384 0.76 KDM4E (0.50) ALDH1A1HPGDKDM4EHSD17B10HTT
SCHEMBL30675634 0.75 ALDH1A1 (0.70) ALDH1A1HPGDKDM4EHSD17B10HTT
SCHEMBL305252 0.75 ALDH1A1 (0.70) ALDH1A1HPGDKDM4EHSD17B10HTT
SCHEMBL28632141 0.75 HTT (0.61) ALDH1A1HPGDKDM4EHSD17B10HTT
Phthalic Acid SCHEMBL27416088 0.74 CYP3A4 (0.61) ALDH1A1HPGDKDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550746-B2 Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators ALLERGAN, INC. (US) 2017-01-24 US disclosed
US-20150218119-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. 2015-08-06 US disclosed
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
US-8927544-B2 Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators ALLERGAN, INC. (US) 2015-01-06 US disclosed
WO-2013130958-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2013-09-06 WO disclosed
US-20130231338-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2013-09-05 US disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218119-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS CXCR2, CCR2, CCR5 ALDH1A1 1991/4885HPGD 773/4885KDM4E 4701/4885
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A ALDH1A1 767/4885HPGD 3169/4885KDM4E 3017/4885
US-20130231338-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS CXCR2, CCR2, CCR5 ALDH1A1 1991/4885HPGD 773/4885KDM4E 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.